Home/Filings/4/0001213900-26-001385
4//SEC Filing

MARTELL RON 4

Accession 0001213900-26-001385

CIK 0001788028other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:30 PM ET

Size

5.7 KB

Accession

0001213900-26-001385

Insider Transaction Report

Form 4
Period: 2026-01-02
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Award

    Stock Option (right to buy)

    2026-01-02+234,000234,000 total
    Exercise: $1.84Exp: 2036-01-02Voting Common Stock (234,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:30 PM ET
Size
5.7 KB